99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy

One hundred eighty-four 99mTc-labeled macroaggregated albumin (99mTc-MAA) perfusion studies were carried out in 39 patients with histologically proven primary (four) and metastatic (35) hepatic neoplasms. Three different patterns of tumor perfusion were observed: (1) increased central radioactivity (33%); (2) decreased central radioactivity (33%); and (3) mixed and/or diffuse radioactivity (33%). Extrahepatic perfusion as evidenced by radioactive localization in the region of the stomach, pancreas, and small bowel was noted in 51%. Its presence was associated with a higher incidence of gastrointestinal complications (45% vs. 16%). Tumor arteriovenous shunting was demonstrated in 38%, showing localization of radiotracer activity in the lungs, and decreased as tumors decreased in size. The use of 99mTc-MAA infusion studies in intrahepatic arterial chemotherapy offers an excellent evaluation of catheter placement and tumor perfusion, in addition to helping to avoid gastrointestinal complications.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Murata, H. Tajima, Y. Abe, T. Fukunaga, K. Nakazawa, R. A. A. Mohamad, and T. Kumazaki Temporary Occlusion of Two Hepatic Veins for Chemoembolization of Hepatocellular Carcinoma with Arteriohepatic Vein Shunts Am. J. Roentgenol., February 1, 2005; 184(2): 415 - 417. [Full Text] [PDF]